Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Leah Andrews, M. Elizabeth Halloran, Lars van der Laan, Yunda Huang et autres
6 citationsJAMA Network Open
Griet Van Roey
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
14Publications signalées
196Citations signalées
0Affiliations récentes
Domaines associés
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesHIV Research and TreatmentVaccine Coverage and HesitancyViral Infections and Outbreaks Research
Publications récentes
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial
Mathieu Le Gars, Jerald Sadoff, Vicky Cárdenas, Dirk Heerwegh et autres
6 citationsVaccine
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals
Leigh H. Fisher, Jia Jin Kee, Albert Liu, Claudia Espinosa et autres
6 citationsJAMA Network Open
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
E Choi, Boris Lacarra, Muhammed O. Afolabi, Boni Maxime Ale et autres
18 citationsThe Lancet Global Health
Risk of COVID-19 after natural infection or vaccination
Anne-Marie Rick, Matthew B. Laurens, Ying Huang, Chenchen Yu et autres
15 citationsEBioMedicine
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults
Deborah Theodore, Angela R Branche, Lily Zhang, Daniel S. Graciaa et autres
23 citationsJAMA Network Open
Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern
Mandy Jongeneelen, Krisztián Kaszás, Daniel Veldman, Jeroen Huizingh et autres
49 citationsbioRxiv (Cold Spring Harbor Laboratory)
Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant
Penny L. Moore, Thandeka Moyo-Gwete, Tandile Hermanus, Prudence Kgagudi et autres
19 citationsbioRxiv (Cold Spring Harbor Laboratory)
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
Moses Badio, Édouard Lhomme, Mark Kieh, Abdoul Habib Béavogui et autres
18 citationsTrials
Chronic upper airway inflammation is characterized by an extrafollicular B cell response and elevated antibody production in humans (HUM1P.260)
Kathryn E. Hulse, Bruce Tan, Richard Kasjanski, Griet Van Roey et autres
0 citationsThe Journal of Immunology
Modulating mucosal immune responses to HIV
0 citations
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen
Mauricio A. Arias, Andrew Loxley, Christy Eatmon, Griet Van Roey et autres
36 citationsVaccine
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.